Neuronatin (NNAT) is a small proteolipid (9kD) with high sequence homology to phospholamban [7, 8], which was also recently identified as a novel modifier of estrogen receptor-positive (ER+) breast cancer incidence and survival [9]. Here, NNAT is linked to breast carcinoma.